Press Releases from Ipsat Therapies Ltd (1 total)
Ipsat Therapies commences patient recruitment in Phase IIb
Helsinki, 4 December 2006: Ipsat Therapies Ltd ('Ipsat') today announces that it has recruited its first patient in a Phase IIb clinical study of its lead product P1A. The study, which is multi-centre, randomized, placebo controlled and double blinded, will further evaluate the safety and efficacy of P1A administered in combination with Ampicillin in preventing the damage to the intestinal microflora caused by the residual beta-lactam antibiotic in hospitalized…
